Fundraising Fox
WinSanTor
San Diego, US · Delaware corporation · 2 known investors
Find your way into WinSanTor
Sign up to see every warm intro you have to WinSanTor
- Paths you didn't know you had: your email and LinkedIn already hold routes to the WinSanTor team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Winsantor is a clinical-stage biotechnology company developing treatments for peripheral neuropathies, including diabetic peripheral neuropathy and chemotherapy-induced peripheral neuropathy. The company is currently advancing its lead drug candidate, WST-057, through Phase 2 clinical trials in Canada.
Founders & leadership
SK
Stan KimCEO and Co-FounderStan Kim is the Executive Officer and Director of WinSanTor, a clinical-stage biotechnology company developing treatments for peripheral neuropathies. He has previously founded multiple technology and healthcare companies.
NC
Nigel CalcuttNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$782.9K disclosed across 1 round · 2017
▶$782.9KraisedNov 2017 · 16 investors · Pharmaceuticals
▶$782.9KraisedNov 2017 · 16 investors · Pharmaceuticals
Officers, directors & promoters on the filing
- Stan KimExecutive Officer, Director
- Nigel CalcuttDirector
- Offering amount
- $2M
- Amount sold
- $782.9K
- Minimum investment
- $20K
- First sale
- May 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 04
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
UbieUbie provides a free AI-powered symptom checker that generates a personalized report on possible causes of a user's symptoms and guidance on when to see a doctor, based on a short questionnaire developed with doctors. The consumer-facing digital health service operates in Japan, the United States, and other countries.
DoctronicDoctronic builds an AI system trained on peer-reviewed medical evidence to provide 24/7 medical triage and consultation, achieving 99.2% alignment with board-certified clinicians. The platform serves patients seeking instant healthcare guidance with no insurance requirement, anonymity, and HIPAA compliance.
OsmosisOsmosis is a US health education platform of short-form medical videos and learning tools, acquired by Elsevier.
Companies working in the same space as WinSanTor.
Frequently asked questions
- What does WinSanTor do?
- Winsantor is a clinical-stage biotechnology company developing treatments for peripheral neuropathies, including diabetic peripheral neuropathy and chemotherapy-induced peripheral neuropathy. The company is currently advancing its lead drug candidate, WST-057, through Phase 2 clinical trials in Canada.
- Who are WinSanTor's investors?
- WinSanTor's investors include Methuselah Funds, Thynk Capital.
- How much funding has WinSanTor raised?
- WinSanTor has disclosed $782.9K raised across 1 round.
- Where is WinSanTor headquartered?
- WinSanTor is headquartered in San Diego, US.